FDA
-
-
-
-
-
-
-
Evolus submits FDA application for Evolysse Sculpt dermal filler
-
-
-
-
-
-
-
Evolus (EOLS) Announces FDA Approval of Evolysse Form and Evolysse Smooth Injectable Hyaluronic Acid Gels
-
-
-
-
-
-
-
Evolus (EOLS) Announces Submission of Premarket Approval Application to the FDA for First Two Evolysse Dermal Filler Products
-
-
-
-
-
-
-
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
-
-
-
-
-
-
-
Evolus (EOLS) Unveils New Branding for Jeuveau
-
-
-
-
-
-
-
Evolus to Present Phase 2 Interim Data from Jeuveau® “Extra-Strength” Dose for Extended Duration Study at 2023 IMCAS World Congress
-
-
-
-
-
-
-
Evolus Celebrates Third Anniversary of the Launch of Jeuveau® in the United States
-
323,148 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

